Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VoluMetrix is a private Nashville-based medical device company developing non-invasive patient monitoring technologies based on proprietary venous waveform analysis. Its core platform, NIVA (Non-Invasive Venous waveform Analysis), is designed to estimate hemodynamic status and congestion using a wrist-worn sensor and signal-analysis software. The company’s lead product, NIVA|HF, is an investigational device for heart failure monitoring that has received FDA Breakthrough Device designation. VoluMetrix appears focused on translating its waveform platform from hospital to home monitoring for patients with heart failure and related fluid-management needs. The business sits at the intersection of medical devices, remote monitoring, and digital health rather than traditional therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VoluMetrix.